|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1998-7-23
|
|
pubmed:abstractText |
Beclomethasone dipropionate (BDP), a topically active steroid, seemed to be an effective treatment for intestinal graft-versus-host disease (GVHD) in a phase I study. The aim of this study was to compare the effectiveness of oral BDP to that of placebo capsules in treatment of intestinal GVHD.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0016-5085
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
115
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
28-35
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9649455-Administration, Oral,
pubmed-meshheading:9649455-Adult,
pubmed-meshheading:9649455-Aged,
pubmed-meshheading:9649455-Beclomethasone,
pubmed-meshheading:9649455-Female,
pubmed-meshheading:9649455-Graft vs Host Disease,
pubmed-meshheading:9649455-Humans,
pubmed-meshheading:9649455-Inflammatory Bowel Diseases,
pubmed-meshheading:9649455-Male,
pubmed-meshheading:9649455-Middle Aged,
pubmed-meshheading:9649455-Prednisone
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial.
|
|
pubmed:affiliation |
Gastroenterology/Hepatology Section, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|
